Author

Vladimira Vasileva Boyadzhieva

Observed names: Boyadzhieva, V., Boyadzhieva, Vladimira, V Boyadzhieva, V. Boyadzhieva, V.V. Boyadzhieva, VV Boyadzhieva, Vladimira Boyadhzieva, Vladimira Boyadzhieva, Vladimira Boyadzieva, Vladimira V. Boyadzhieva, Vladimira V. Boyadzieva, Бояджиева/Boyadjieva, Владимира Василева/Vladimira Vasileva

Institutions: Medical University of Sofia, University Hospital St. Ivan Rilski

Observed institutions: Medical University of Sofia, University Hospital St. Ivan Rilski, ZHAW Zurich University of Applied Sciences

ORCID: 0000-0002-6780-5810

Observed ORCID: 0000-0002-6780-5810

OpenAlex ID: A5047688414

EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update

2024 · Tuva Moseng, Theodora P M Vliet Vlieland, et al. · Annals of the Rheumatic Diseases · 434

EULAR recommendations for the treatment of systemic sclerosis: 2023 update

2024 · Francesco Del Galdo, Alain Lescoat, et al. · Annals of the Rheumatic Diseases · 326

EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update

2025 · Linda Rüegg, Andrea Pluma, et al. · Annals of the Rheumatic Diseases · 204

European multicentre pilot survey to assess vitamin D status in rheumatoid arthritis patients and early development of a new Patient Reported Outcome questionnaire (D-PRO)

2017 · Jelena Vojinovic, Angela Tincani, et al. · Autoimmunity Reviews · 56

Impact of lumbar syndesmophyte on bone health as assessed by bone density (BMD) and bone texture (TBS) in men with axial spondyloarthritis

2016 · Laura Wildberger, Vladimira Boyadzhieva, et al. · Joint Bone Spine · 44

Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis

2017 · Fausto Salaffi, Marco Di Carlo, et al. · Joint Bone Spine · 43

Treg/Th17 cell balance and phytohaemagglutinin activation of T lymphocytes in peripheral blood of systemic sclerosis patients

2017 · Ekaterina Krasimirova, Tsvetelina Velikova, et al. · World Journal of Experimental Medicine · 43

EULAR recommendations for the management of Behçet’s syndrome: 2025 update

2026 · Gulen Hatemi, Sofia Ramiro, et al. · Annals of the Rheumatic Diseases · 40

Quality of Life and Cost Study of Rheumatoid Arthritis Therapy With Biological Medicines

2018 · Vladimira V. Boyadzieva, Nikolay Stoilov, et al. · Frontiers in Pharmacology · 27

EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis: 2025 update

2026 · Anne-Kathrin Rausch Osthoff, Theodora P M Vliet Vlieland, et al. · Annals of the Rheumatic Diseases · 22

Op0234 2023 Update of Eular Recommendations for the Treatment of Systemic Sclerosis

2023 · F. Del Galdo, A. Lescoat, et al. · Annals of the Rheumatic Diseases · 15

Ab1439 Update of the Eular Points to Consider for Use of Antirheumatic Drugs in Reproduction, Pregnancy and Lactation

2024 · F. Förger, A. Pluma Sanjurjo, et al. · Annals of the Rheumatic Diseases · 14

Did the Introduction of Biosimilars Influence Their Prices and Utilization? The Case of Biologic Disease Modifying Antirheumatic Drugs (bDMARD) in Bulgaria

2021 · Konstantin Tachkov, Zornitsa Mitkova, et al. · Pharmaceuticals · 13

Management of major organ involvement in Behçet syndrome: a systematic literature review informing the 2025 update of the EULAR recommendations

2026 · Yesim Ozguler, Sinem Nihal Esatoglu, et al. · EULAR Rheumatology Open · 10

Real World Experience of Disease Activity in Patients With Rheumatoid Arthritis and Response to Treatment With Varios Biologic DMARDs

2018 · Vladimira Boyadzhieva, Nikolay Stoilov, et al. · Frontiers in Pharmacology · 10

Is There a Symmetry in Disease Control and Quality of Life of Patients with Rheumatoid Arthritis Treated with Biological Therapy?

2021 · Konstantin Tachkov, Vladimira Boyadzhieva, et al. · Symmetry · 9

Coronavirus disease 2019 (COVID-19) during pregnancy in patients with rheumatic diseases

2020 · Vladimira Vasileva Boyadzhieva, Nikolay Rumenov Stoilov, et al. · Rheumatology International · 9

Management of mucocutaneous and joint involvement of Behçet’s syndrome: a systematic literature review informing the 2025 update of the EULAR recommendations

2026 · Sinem Nihal Esatoglu, Yesim Ozguler, et al. · EULAR Rheumatology Open · 8

SARS-CoV-2 and autoimmune rheumatic diseases

2021 · Nikolay Stoilov, Vladimira Boyadzhieva · Rheumatology (Bulgaria) · 7

Clinical and immune-related manifestations in patients with COVID-19

2023 · Jaklin Svetoslavova Doncheva - Dilova, Vladimira Boyadzhieva, et al. · Rheumatology (Bulgaria) · 6

Treatment of rheumatoid arthritis: csDMARDS versus bDMARDS. Prospective study to evaluate disease activity

2019 · Vladimira Boyadzhieva, Nikolai Stoilov, et al. · 5

Capillaroscopy in COVID-19

2023 · Jaklin Svetoslavova Doncheva - Dilova, Vladimira Boyadzhieva, et al. · Rheumatology (Bulgaria) · 4

Quality of life and disease activity of patients with rheumatoid arthritis on tofacitinib and biologic disease-modifying antirheumatic drug therapies

2022 · Vladimira Boyadzhieva, Konstantin Tachkov, et al. · Rheumatology International · 4

Systemic sclerosis in mother and daughter with susceptible HLA haplotype and anti-topoisomerase I autoantibodies

2020 · Ekaterina Krasimirova Kurteva, Vladimira Vasileva Boyadzhieva, et al. · Rheumatology International · 4

Relationship between physical function, disease activity, spinal mobility and bone parameters (trabecular bone score and bone mineral density) in ankylosing spondylitis patients

2015 · Mariana Ivanova, Irena Manolova, et al. · Biotechnology & Biotechnological Equipment · 4

Works count: 108

Citation count: 1,413

H-index: 13

I10-index: 15